• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Long-acting antiseptic for hygienic friction washing and pre-surgical hand washing. The present invention describes a chemical composition that solves the progressive loss of antisepsis of biocidal agents for antiseptic use. This composition is a unique combination of three biocidal substances with legally recognized action and indication and free of any adverse or harmful effect. It consists of the unique combination of three biocidal substances and water where one biocidal agent is an alcohol, another biocidal agent is a halogenated compound, and a third substance is an antimicrobial food additive. The immediate and sustained antiseptic effectiveness of the described hydroalcoholic formulation is much higher compared to other commercially used antiseptics. The antiseptic can be used for domestic or sanitary uses. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2784275A1
    申请号:ES202030346
    申请日:2020-04-24
    公开日:2020-09-23
    发明作者:De Bengoa Y Vallejo Ricardo Becerro；Fernandez David Sevillano；Cervera Luis Alou；Hidalgo Natalia Gonzalez；Iglesias Marta Elena Losa
    申请人:Universidad Complutense de Madrid；
    IPC主号:
    专利说明:

    [0001] Long-acting antiseptic for hygienic friction washing and pre-surgical hand washing
    [0003] TECHNICAL SECTOR
    [0005] The present invention falls within the healthcare sector. More specifically, it refers to an antiseptic for hygienic washing for personal or medical use.
    [0007] BACKGROUND OF THE INVENTION
    [0009] Antiseptics are biocidal agents of low toxicity (or, in any case, of lower toxicity than disinfectants) with indications of preferential use on intact, altered skin or human mucosa where they destroy or prevent the proliferation of pathogenic microorganisms.
    [0011] The antiseptic agents used most frequently in our environment belong to the chemical group of alcohols (such as ethanol or ethyl alcohol, propanol-1 (propanol) and pronpanol-2 or isopropyl alcohol), to the chemical group of halogenated compounds (such as iodines ), the group of biguanides (such as chlorhexidine) and phenolic derivatives (such as bisphenols); Hexachlorophen (currently replaced by triclosan or halophenols) and chloroxylenol or PCMX are also widely used.
    [0013] The chemical structure of antiseptics defines the mechanisms of action on sensitive microorganisms, the spectrum of activity and the immediate and long-term antimicrobial action. This last parameter (prolonged action over time), is closely linked to the residual action of the biocide and, in general, is predetermined by the stability of the biocidal agent to the external environment (temperature, pH, among others), the presence of inactivating organic matter or simultaneous application with other chemical inhibitory agents.
    [0015] The antisepsis of the hands of healthcare personnel, channeled through the processes of hygienic washing and pre-surgical hand washing, is one of the most widespread uses of antiseptics on intact skin and in the clinical setting. They are simple and strictly protocolized procedures that seek to sufficiently reduce the habitual resident burden and eliminate the transient pathogenic microbial flora from the skin of healthcare personnel. The antisepsis of intact skin on the hands of healthcare personnel limits the proliferation of the microbial load and subsequent dissemination to the patient, thereby reducing the risk of infection during patient handling, especially at the surgical site.
    [0017] Disinfection protocols rarely include the application of a single antiseptic. The sequential application of different antiseptics, under strictly defined contact times, is a common practice that guarantees immediate and prolonged skin disinfection. Similarly, the application of antiseptics by aggressive brushing is preferred because of the general belief that it leads to more effective antisepsis and, therefore, greater safety for the patient.
    [0019] Any proposal for a biocidal agent or combinations of biocidal agents with options for use as antiseptic agents in Spain must demonstrate the microbicidal properties implicitly included in the European regulation UNE-EN 14885 and, specifically according to their possible applications, those included in the UNE-EN standards 1499: 21033 (referring to hand washing), UNE-EN 1500: 2013 (referring to hygienic treatment of hands by friction) or UNE-EN 12791: 2016 + A1: 2018 (referring to pre-operative hand washing) . This latest standard, the UNE EN 12971: 2016 + A1: 2018 standard, combines the strictest effectiveness and safety criteria of all existing ones, assuming that compliance with this regulation enables the biocidal agent for approval in other potential applications.
    [0021] The biocidal agents marketed and involved in pre-operative antisepsis in the hands of healthcare personnel claim said regulations, as they exhibit an immediate and prolonged effect not less than that of the reference antiseptic (60% propanol-1).
    [0023] However, it is a fact widely described in the scientific literature that the microbicidal properties of both the reference antiseptic and the rest of the agents marketed to date progressively and significantly decrease. its action within three hours after its application (effect 3 hours or prolonged according to the regulations described above) with respect to the immediate effect previously quantified. This unavoidable loss of activity favors the microbial recolonization of the skin and shortens the safety of antisepsis, seriously endangering the infection of the patient who undergoes medium and long-term interventions or repeated short-term interventions without prior re-initiation of antisepsis.
    [0025] Therefore, it would be desirable to have an antiseptic with immediate action and that confers an asepsis that is maintained over time greater than that conferred by the reference antiseptic.
    [0027] EXPLANATION OF THE INVENTION
    [0029] The present invention describes a chemical composition that solves the progressive loss of antisepsis of biocidal agents for antiseptic use. This composition is a unique combination of three biocidal substances with action and indication legally recognized in Spain, formulated with concentrations admitted by the competent authorities and, therefore, free of any adverse or harmful effect other than those implicitly included in the technical specifications of the combined agents.
    [0031] More specifically, the antiseptic of the present invention is a hydroalcoholic formulation that consists of the unique combination of three biocidal substances and water where one biocidal agent is an alcohol, another biocidal agent is a halogenated compound and a third substance is a food additive. antimicrobial.
    [0033] Antiseptics intended for hand antisepsis are currently liquid or soapy products that include chemical biocidal active ingredients such as alcohol, povidone iodine, chlorhexidine glutonate, or chloroxylenol.
    [0035] Apart from biocides with antiseptic or disinfectant capacity, there is a set of biocides that, due to their antimicrobial properties and low or no toxicity on the host, are used for technological purposes in the preparation, food storage and preservation. They are known as food additives. At the international level, these biocides or additives are collected and regulated through the Codex Alimentarius or joint food standard edited by the FAO (Food and Agriculture Organization of the United Nations) and the WHO (World Health Organization). Among these additives is potassium sorbate (E-202), a derivative of ascorbic acid with a food preservative function due to its properties to inhibit the growth of microorganisms for long periods of time.
    [0037] The formulation presented in this invention is a hydroalcoholic formulation that includes two antiseptic biocidal agents commonly used to disinfect intact skin (ethanol and chlorhexidine gluconate) and a food additive commonly used in food preservation (potassium sorbate). . The ethanol concentration is in the range 60-70 % (v / v), the concentration of chlorhexidine gluconate is in the range 0.5 - 4%% (v / v), the potassium sorbate concentration is in the range between 0.3-0.6%% (v / v); the rest is deionized water.
    [0039] Ethanol, like other alcohols, has a rapid action mechanism based on the denaturation of proteins in the presence of water and without any residual activity. It exhibits a broad antimicrobial spectrum that includes gram-positive and gram-negative bacteria, fungi, and viruses in general.
    [0041] Chlorhexidine has a spectrum of action very similar to alcohols, although in vitro it only shows activity on enveloped viruses (such as herpes simplex virus, HIV, cytomegalovirus, influenza and RSV, among others). Chlorhexidine is a cationic molecule that binds to negatively charged cell wall structures. At low concentrations, it affects the integrity of the cell wall, interfering with the natural osmosis process. The immediate effect is slower than that of alcohols, although the residual activity is substantial.
    [0043] The non-ionized potassium sorbate shows, unlike chlorhexidine, good diffusion through cell membranes. It is attributed a direct mechanism of action on the membrane, triggering effects similar to chlorhexidine but of less intensity. It has also been linked to a certain inhibitory effect of cellular metabolism. It has a limited immediate activity, directed at bacteria and fungi, and a broad residual activity.
    [0045] The immediate antiseptic effectiveness and maintained over time of the hydroalcoholic formulation described is much higher compared to other commercially used antiseptics.
    [0047] In the immediate antiseptic effect of the hydroalcoholic formulation of the present invention, the action of alcohol prevails, although chlorhexidine gluconate and potassium sorbate contribute to the final extent of the effect. However, the absence of residual effects on alcohols makes chlorhexidine and potassium sorbate responsible for the prolonged maintenance of asepsis in the hydroalcoholic formulation of the present invention; in particular, it is a consequence of the potentiated effects of potassium sorbate, which indirectly triggers the action of chlorhexidine.
    [0049] Residual concentrations of chlorehexidine and potassium sorbate to preserve the skin from recolonization by the resident microbiota at least three hours after application of the formulation.
    [0051] The combination of these agents gives the composition an antisepsis maintained over time that is significantly higher than that given by the reference biocide established by the European standard UNE-EN 12791: 2016 + A1: 2018.
    [0053] The formulation is applied by brushing or by direct friction with the skin with a contact time of at least 1 minute, without the need for aggressive brushing or rinsing.
    [0055] Due to the prolongation of asepsis and its ease of application, the hydroalcoholic formulation of the present invention can be used in the home and healthcare environment for hygienic hand washing and pre-surgical hand washing. Its characteristics make it easy to adhere to the procedure, provide greater security in the management of infections and confer a lower risk of infection of the surgical site in medium and long-term interventions.
    [0056] It can also be used as a component in the manufacture of other hygienic products such as wipes, hand washing products or in the manufacture of products for cleaning clothes or surfaces, among others.
    [0058] BRIEF DESCRIPTION OF THE DRAWINGS
    [0060] Figure 1 is attached as an integral part of the invention, where, by way of illustration and not limitation, the immediate and prolonged effect of 3 hours (reduction of the basal bacterial load) of the hydroalcoholic formulation of the present invention compared to the reference antiseptic propanol-1.
    [0062] Below is a list of the different elements represented in the figures that are integrated into the invention:
    [0064] 101 = immediate effect of propanol-1
    [0065] 102 = immediate effect of the hydroalcoholic formulation
    [0066] 201 = prolonged effect of propanol-1 at 3 h
    [0067] 202 = effect prolonged at 3 h of the hydroalcoholic formulation
    [0069] PREFERRED EMBODIMENT OF THE INVENTION
    [0070] The present invention is illustrated by the following examples, which are not intended to be limiting of its scope.
    [0072] Example 1.
    [0073] In this example a composition of the hydroalcoholic formulation is described.
    [0075] The hydroalcoholic formulation is composed of ethanol (70% v / v), chlorhexidine gluconate (3% v / v), potassium sorbate (0.3% v / v) and deionized water. This formulation is called SORBECTOL (Trade name registered in OEPM N0414614).
    [0077] Example 2.
    [0078] This example describes the antiseptic properties of the hydroalcoholic formulation.
    [0079] The antiseptic properties of the hydroalcoholic formulation were tested through a clinical trial in healthy volunteers, following the design and evaluation criteria specified in the UNE-EN 12971: 2016 standard. The trial, approved by the Ethics Committee for Clinical Research of the Hospital Universitario San Carlos de Madrid with the internal code 18/237-R_X, involved 24 volunteers who were instructed in hand washing.
    [0081] The hydroalcoholic formulation described in Example 1 (SORBITOL) was used. In each case, a volume of 3 ml was applied and spread by friction, maintaining a contact time of 1 minute.
    [0083] As measures of antimicrobial effect, the following were adopted:
    [0084] (I) the immediate effect or reduction of the microbial load of the skin immediately after the application of the antiseptic (MI) with respect to the basal microbial load (MB) obtained immediately after hand washing with soap and immediately before antisepsis . (II) The effect prolonged to 3 hours or reduction of the microbial load of the skin protected with sterile latex gloves without powder, 3 hours after the start of antisepsis (PM).
    [0086] Both effects were calculated from the count of Colony Forming Units (CFU) per ml of sample (in the form of a logarithm in base 10) at the MIB, MI and MP moments, using the expressions:
    [0088] Immediate effect = MI - MB
    [0089] Long-term effect = MP - MB
    [0091] In this way, obtaining a positive value indicates the reduction of the microbial load at a given time.
    [0093] It turned out that SORBECTOL exhibits an immediate effect of 3.77 ± 0.64 log CFU / ml and a prolonged effect at 3 hours of 3.12 ± 0.82 log CFU / ml (expressed as the mean ± the standard deviation of the test ), complying with the effectiveness requirements demanded in the UNE-EN 12971: 2016 regulation.
    [0094] Example 3.
    [0095] In this example, antiseptic properties of the hydroalcoholic formulation are compared with the reference antiseptic.
    [0097] Propanol-1 at 60% v / v is used as a reference antiseptic and it was compared with the hydroalcoholic formulation of the previous examples (SORBECTOL). The reference antiseptic was proceeded in the same way as with SORBECTOL as described in example 2.
    [0099] The immediate and prolonged effect at 3 hours quantified for SORBECTOL against the reference antiseptic (propanol-1 at 60% v / v) is summarized in Figure 1.
    [0100] - SORBECTOL exhibits an immediate effect (102) significantly higher (3.77 ± 0.64 log CFU / ml vs. 2.01 ± 1.06 log CFU / ml, p <0.0001, Wilcoxon Signed Rank Test) than propanol -1 to 60% (101).
    [0101] - SORBECTOL exhibits a prolonged effect at 3 hours (202) significantly higher (3.12 ± 0.82 log CFU / ml vs. 1.02 ± 0.79 log CFU / ml, p <0.0001, Wilcoxon Signed Rank Test ) to 60% propanol-1 (201).
    [0103] Furthermore, it turned out that SORBECTOL, unlike the reference antiseptic, does not show significant loss of antimicrobial activity after the maximum test time established by the European reference standard with respect to the effect achieved immediately after application on intact skin.
    [0105] Example 4.
    [0106] In this example, the activity of the components of the hydroalcoholic formulation is evaluated separately or in combination in pairs and in different ways of application: aggressive brushing or friction.
    [0108] Following the UNE-EN 12791: 2016 standard, chlorhexidine gluconate applied at 5% by brushing or friction, the combinations of ethanol and chlorhexidine gluconate applied, either by friction or brushing, or the combination of ethanol and potassium sorbate, both are tested applied by friction.
    [0110] It turned out that none of these antiseptics separately or in combination in pairs did not present a prolonged effect significantly different from that of the antiseptic. reference propanol-1. Therefore, the immediate effectiveness of the formulation is a consequence of the joint action of the three biocides present in the hydroalcoholic formulation, while the prolonged effectiveness would lie exclusively in the properties of chlorhexidine gluconate and potassium sorbate and, in particular, of the potentiated effects of potassium sorbate, which indirectly triggers the action of chlorehexidine.
    [0112] The mechanism of action of chlorhexidine with potassium sorbate is reminiscent of that of the latter with sodium chloride (van der Waals, SV. Et al. Sodium chioride and potassium sórbate; a synergistic combination against Enterococcus faecaiis biofiims: an in vitro study. Eur. J. Oral. Sci. 2012 Oct; 120 (5): 452-7) and could be the result of the confluence of the effect of osmotic stress caused by chlorhexidine and the subsequent accumulation of potassium and sorbate ions inside of the cell. The effect of chlorhexidine on the cohesion of the cell membrane causes changes in the osmotic permeability of the membrane with the consequent loss of intracellular water (hyperosmotic state). The loss of turgor of the membrane can stimulate the cell to passively accumulate solutes, favoring the passage of undissociated, hydrophobic and well-diffusing sorbate through the membrane, or actively favoring the intracellular accumulation of potassium and sorbic acid ions. . Potassium ions impair enzymatic metabolism as a result of increased ionic charge, and sorbic acid and sorbate ions disrupt metabolism and destabilize cell membranes, contributing to membrane destabilization by chlorhexidine.
    权利要求:
    Claims (11)
    [1]
    1. Long-acting antiseptic with a hydroalcoholic formulation consisting of the unique combination of three biocidal substances and water where one biocidal agent is an alcohol, another biocidal agent is a halogenated compound and a third substance is an antimicrobial food additive.
    [2]
    2. Long-acting antiseptic, according to claim 1, where the biocidal substances are ethanol, chlorhexidine gluconate and potassium sorbate.
    [3]
    3. Long-acting antiseptic, according to claim 2, where the ethanol concentration is in the range 60-70% (v / v), the chlorhexidine gluconate concentration is in the range 0.5 - 4% (v / v), the potassium sorbate concentration is in the range 0.3-0.6% (v / v) and the remainder is deionized water.
    [4]
    4. Long-acting antiseptic, according to claim, where the ethanol concentration is 70% (v / v), the chlorhexidine gluconate concentration is 3% (v / v), the potassium sorbate concentration is between 0 , 3% (v / v) and the rest is deionized water.
    [5]
    5. Antiseptic according to any one of claims 1 to 4, characterized in that it is applied by friction or brushing.
    [6]
    6. Antiseptic, according to any of claim 5, characterized in that it is applied by direct friction with the skin with a contact time of at least 1 minute.
    [7]
    7. Use of the claimed antiseptic for hygienic hand washing in the home environment.
    [8]
    8. Use of the claimed antiseptic for hygienic hand washing in a sanitary environment.
    [9]
    9. Use of the claimed antiseptic for pre-surgical hand washing.
    [10]
    10. Use of the claimed antiseptic in the manufacture of a hygienic product.
    [11]
    11. Use of the claimed antiseptic in the preparation of a product for cleaning clothes or surfaces.
    类似技术:
    公开号 | 公开日 | 专利标题
    Hübner et al.2010|Octenidine dihydrochloride, a modern antiseptic for skin, mucous membranes and wounds
    ES2360803T3|2011-06-09|COMPOSITIONS AND ANTIMICROBIAL THERAPEUTIC METHODS.
    ES2846854T3|2021-07-29|Antiseptic compositions comprising silver and menthol ions and uses thereof
    US20090170947A1|2009-07-02|Disinfectant compositions, methods and systems
    CN111297704A|2020-06-19|Foam disinfection composition with sterilization and skin care functions and preparation method and application thereof
    ES2423730T3|2013-09-24|Use of a synergistic composition as a therapeutic agent or disinfection agent
    KR102096254B1|2020-04-06|Preservative composition comprising unityol and dimethylsulfoxide, use of composition and method of treating wound using same
    ES2784275B2|2021-04-15|Long-acting antiseptic for hygienic scrubbing and pre-surgical hand washing
    JP2022506394A|2022-01-17|Compositions for treating biofilms without inducing drug resistance
    JP2022506384A|2022-01-17|Compositions and Methods for Treating Transient Biofilms
    ES2829283T3|2021-05-31|Antimicrobial and cleansing composition consisting of a polymeric biguanide and EDTA
    RU2292919C1|2007-02-10|Agent for skin integument disinfection
    US20200061106A1|2020-02-27|Compositions and methods for treating biofilms without inducing antimicrobial resistance
    US20200061107A1|2020-02-27|Compositions and methods for treating transient biofilms
    BR102020004724A2|2021-09-21|TOPIC FORMULATIONS FOR USE IN SURGICAL FIELD ASEPSY OF DOMESTIC ANIMALS BASED ON POLYHEXAMETHYLENE HYDROCHLORIDE WHICH OR NOT ASSOCIATED WITH CHLOREXIDINE.
    US9155709B1|2015-10-13|Buffered hydroalcoholic povidone iodine composition and method
    CN113521042A|2021-10-22|Alcohol-free wash-free virus inactivation disinfectant special for children and preparation method thereof
    RU2517031C1|2014-05-27|Biocidal composition for soaking napkins
    US20180177823A1|2018-06-28|Compositions and methods for aerodigestive treatment
    Simon et al.2007|Comparison of the antimicrobial efficacy of topical antiseptic creams on canine wounds
    AU2018309734A1|2020-05-28|Alkyl dimethyl organosilane quaternaries in persistent systems and methods
    JP2006117587A|2006-05-11|Germicidal disinfectant composition
    Negash et al.0|Common Antiseptics: Mechanism Of Action And Its Uses In Animal
    同族专利:
    公开号 | 公开日
    WO2021214361A1|2021-10-28|
    ES2784275B2|2021-04-15|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US6383997B1|2001-07-02|2002-05-07|Dragoco Gerberding & Co. Ag|High lathering antibacterial formulation|
    WO2004084973A2|2003-03-24|2004-10-07|Becton, Dickinson And Company|Invisible antimicrobial glove and hand antiseptic|
    CN105769635A|2014-12-24|2016-07-20|阎珊珊|Preparation of anti-bacterial hand-washing solution|
    CN108653121A|2017-03-31|2018-10-16|景有超|A kind of antibacterial type disinfecting liquid containing medicinal herb components|
    法律状态:
    2020-09-23| BA2A| Patent application published|Ref document number: 2784275 Country of ref document: ES Kind code of ref document: A1 Effective date: 20200923 |
    2021-04-15| FG2A| Definitive protection|Ref document number: 2784275 Country of ref document: ES Kind code of ref document: B2 Effective date: 20210415 |
    优先权:
    申请号 | 申请日 | 专利标题
    ES202030346A|ES2784275B2|2020-04-24|2020-04-24|Long-acting antiseptic for hygienic scrubbing and pre-surgical hand washing|ES202030346A| ES2784275B2|2020-04-24|2020-04-24|Long-acting antiseptic for hygienic scrubbing and pre-surgical hand washing|
    PCT/ES2021/070260| WO2021214361A1|2020-04-24|2021-04-20|Long lasting antiseptic for hygienic friction washing and pre-surgical washing of hands|
    [返回顶部]